Logo image of ELMD

ELECTROMED INC (ELMD) Stock Fundamental Analysis

NYSEARCA:ELMD - NYSE Arca - US2854091087 - Common Stock - Currency: USD

27.97  -0.66 (-2.31%)

After market: 27.97 0 (0%)

Fundamental Rating

8

We assign a fundamental rating of 8 out of 10 to ELMD. ELMD was compared to 190 industry peers in the Health Care Equipment & Supplies industry. ELMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ELMD is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make ELMD a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year ELMD was profitable.
In the past year ELMD had a positive cash flow from operations.
In the past 5 years ELMD has always been profitable.
Of the past 5 years ELMD 4 years had a positive operating cash flow.
ELMD Yearly Net Income VS EBIT VS OCF VS FCFELMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

With an excellent Return On Assets value of 13.22%, ELMD belongs to the best of the industry, outperforming 94.15% of the companies in the same industry.
The Return On Equity of ELMD (15.59%) is better than 92.02% of its industry peers.
ELMD's Return On Invested Capital of 15.21% is amongst the best of the industry. ELMD outperforms 95.74% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ELMD is in line with the industry average of 8.19%.
The last Return On Invested Capital (15.21%) for ELMD is above the 3 year average (8.56%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.22%
ROE 15.59%
ROIC 15.21%
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
ELMD Yearly ROA, ROE, ROICELMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ELMD has a better Profit Margin (11.34%) than 87.23% of its industry peers.
ELMD's Profit Margin has improved in the last couple of years.
ELMD has a better Operating Margin (14.68%) than 84.57% of its industry peers.
In the last couple of years the Operating Margin of ELMD has grown nicely.
ELMD's Gross Margin of 76.62% is amongst the best of the industry. ELMD outperforms 89.89% of its industry peers.
In the last couple of years the Gross Margin of ELMD has remained more or less at the same level.
Industry RankSector Rank
OM 14.68%
PM (TTM) 11.34%
GM 76.62%
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
ELMD Yearly Profit, Operating, Gross MarginsELMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ELMD is creating some value.
Compared to 1 year ago, ELMD has more shares outstanding
The number of shares outstanding for ELMD has been increased compared to 5 years ago.
There is no outstanding debt for ELMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ELMD Yearly Shares OutstandingELMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ELMD Yearly Total Debt VS Total AssetsELMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ELMD has an Altman-Z score of 22.49. This indicates that ELMD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 22.49, ELMD belongs to the top of the industry, outperforming 95.74% of the companies in the same industry.
ELMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 22.49
ROIC/WACC1.68
WACC9.06%
ELMD Yearly LT Debt VS Equity VS FCFELMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ELMD has a Current Ratio of 5.53. This indicates that ELMD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.53, ELMD belongs to the best of the industry, outperforming 80.32% of the companies in the same industry.
A Quick Ratio of 5.06 indicates that ELMD has no problem at all paying its short term obligations.
ELMD has a better Quick ratio (5.06) than 82.98% of its industry peers.
Industry RankSector Rank
Current Ratio 5.53
Quick Ratio 5.06
ELMD Yearly Current Assets VS Current LiabilitesELMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

8

3. Growth

3.1 Past

ELMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.67%, which is quite impressive.
Measured over the past years, ELMD shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.42% on average per year.
The Revenue has grown by 13.83% in the past year. This is quite good.
The Revenue has been growing by 11.82% on average over the past years. This is quite good.
EPS 1Y (TTM)66.67%
EPS 3Y30.66%
EPS 5Y20.42%
EPS Q2Q%15.79%
Revenue 1Y (TTM)13.83%
Revenue growth 3Y15.24%
Revenue growth 5Y11.82%
Sales Q2Q%18.78%

3.2 Future

ELMD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.26% yearly.
ELMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.88% yearly.
EPS Next Y44.21%
EPS Next 2Y29.26%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.66%
Revenue Next 2Y13.88%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ELMD Yearly Revenue VS EstimatesELMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ELMD Yearly EPS VS EstimatesELMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 37.29, which means the current valuation is very expensive for ELMD.
71.81% of the companies in the same industry are more expensive than ELMD, based on the Price/Earnings ratio.
ELMD's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 29.63.
Based on the Price/Forward Earnings ratio of 28.86, the valuation of ELMD can be described as expensive.
ELMD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ELMD is cheaper than 74.47% of the companies in the same industry.
ELMD is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 37.29
Fwd PE 28.86
ELMD Price Earnings VS Forward Price EarningsELMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ELMD indicates a somewhat cheap valuation: ELMD is cheaper than 73.94% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ELMD is valued cheaper than 88.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.19
EV/EBITDA 24.45
ELMD Per share dataELMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

ELMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELMD has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ELMD's earnings are expected to grow with 29.26% in the coming years.
PEG (NY)0.84
PEG (5Y)1.83
EPS Next 2Y29.26%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ELMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ELECTROMED INC

NYSEARCA:ELMD (2/21/2025, 8:15:35 PM)

After market: 27.97 0 (0%)

27.97

-0.66 (-2.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11 2025-02-11/amc
Earnings (Next)05-05 2025-05-05
Inst Owners44.13%
Inst Owner Change30.15%
Ins Owners7.62%
Ins Owner Change2.84%
Market Cap239.42M
Analysts82.86
Price Target36.72 (31.28%)
Short Float %3.89%
Short Ratio2.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)231.47%
Min EPS beat(2)40.06%
Max EPS beat(2)422.88%
EPS beat(4)4
Avg EPS beat(4)144.35%
Min EPS beat(4)28.21%
Max EPS beat(4)422.88%
EPS beat(8)6
Avg EPS beat(8)89.16%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.73%
Min Revenue beat(2)-3.06%
Max Revenue beat(2)6.52%
Revenue beat(4)2
Avg Revenue beat(4)0.73%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)6.52%
Revenue beat(8)4
Avg Revenue beat(8)0.82%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.09%
PT rev (3m)9.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)26.15%
EPS NY rev (3m)26.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)2.09%
Revenue NY rev (3m)3.59%
Valuation
Industry RankSector Rank
PE 37.29
Fwd PE 28.86
P/S 4.2
P/FCF 21.19
P/OCF 20.6
P/B 5.77
P/tB 5.86
EV/EBITDA 24.45
EPS(TTM)0.75
EY2.68%
EPS(NY)0.97
Fwd EY3.46%
FCF(TTM)1.32
FCFY4.72%
OCF(TTM)1.36
OCFY4.85%
SpS6.67
BVpS4.85
TBVpS4.77
PEG (NY)0.84
PEG (5Y)1.83
Profitability
Industry RankSector Rank
ROA 13.22%
ROE 15.59%
ROCE 20.19%
ROIC 15.21%
ROICexc 22.84%
ROICexgc 23.4%
OM 14.68%
PM (TTM) 11.34%
GM 76.62%
FCFM 19.8%
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
ROICexc(3y)11.98%
ROICexc(5y)12.69%
ROICexgc(3y)12.25%
ROICexgc(5y)13.03%
ROCE(3y)11.36%
ROCE(5y)11.53%
ROICexcg growth 3Y14.49%
ROICexcg growth 5Y7.69%
ROICexc growth 3Y14.84%
ROICexc growth 5Y7.9%
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
F-Score8
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 37.78%
Cap/Sales 0.56%
Interest Coverage 250
Cash Conversion 125.98%
Profit Quality 174.68%
Current Ratio 5.53
Quick Ratio 5.06
Altman-Z 22.49
F-Score8
WACC9.06%
ROIC/WACC1.68
Cap/Depr(3y)189.91%
Cap/Depr(5y)155.01%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.67%
EPS 3Y30.66%
EPS 5Y20.42%
EPS Q2Q%15.79%
EPS Next Y44.21%
EPS Next 2Y29.26%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.83%
Revenue growth 3Y15.24%
Revenue growth 5Y11.82%
Sales Q2Q%18.78%
Revenue Next Year15.66%
Revenue Next 2Y13.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y104.02%
EBIT growth 3Y27.97%
EBIT growth 5Y18.35%
EBIT Next Year113.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y440.88%
FCF growth 3Y48.86%
FCF growth 5Y48.48%
OCF growth 1Y744.12%
OCF growth 3Y43.37%
OCF growth 5Y28.48%